Enriched bovine IgG fraction prevents infections with Enterohaemorrhagic O157:H7, serovar Enteritidis, and .
Clicks: 144
ID: 27314
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
76.7
/100
144 views
115 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A bovine IgG-enriched whey fraction contains antibodies against various bacterial antigens. We investigated the protective effects of a bovine whey fraction preparation against infections with Enterohaemorrhagic O157:H7, serovar Enteritidis, and in mouse models. After infection with these pathogens, the IgG-enriched fraction or skim milk was given ad libitum at a 5% solution instead of water. The mice given the IgG-enriched fraction were significantly resistant to orally challenged EHEC O157:H7 (LD: 4.0 × 10 CFU/mouse) infections compared with the mice given skim milk (LD: <1.5 × 10 CFU/mouse). The mice given the IgG-enriched fraction were also significantly resistant to orally challenged Enteritidis (LD: 5.0 × 10 CFU/mouse) infections compared with the mice given skim milk (LD: <2.5 × 10 CFU/mouse). When the mice were nasally infected with , the numbers of the bacteria in lungs of mice given the IgG-enriched fraction were significantly lower than those given skim milk 2 and 3 weeks after infection. These results strongly indicate that oral administration of the bovine IgG-enriched whey fraction protects mice against food-borne infection and also that it partially protects mice against respiratory tract infection.
Reference Key |
funatogawa2019enrichedfood
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Funatogawa, Keiji;Tada, Tatsuya;Kuwahara-Arai, Kyoko;Kirikae, Teruo;Takahashi, Masao; |
Journal | Food science & nutrition |
Year | 2019 |
DOI | 10.1002/fsn3.1134 |
URL | |
Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.